HK1216614A1 - 治療脂肪肝疾病的方法 - Google Patents

治療脂肪肝疾病的方法

Info

Publication number
HK1216614A1
HK1216614A1 HK16104631.9A HK16104631A HK1216614A1 HK 1216614 A1 HK1216614 A1 HK 1216614A1 HK 16104631 A HK16104631 A HK 16104631A HK 1216614 A1 HK1216614 A1 HK 1216614A1
Authority
HK
Hong Kong
Prior art keywords
treatment
liver disease
fatty liver
fatty
disease
Prior art date
Application number
HK16104631.9A
Other languages
English (en)
Inventor
劉勝勇
溫武哲
陳志銘
Original Assignee
Golden Biotechnology Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Golden Biotechnology Corp filed Critical Golden Biotechnology Corp
Publication of HK1216614A1 publication Critical patent/HK1216614A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/07—Basidiomycota, e.g. Cryptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4875—Compounds of unknown constitution, e.g. material from plants or animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Botany (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Physiology (AREA)
  • Dispersion Chemistry (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HK16104631.9A 2013-03-13 2016-04-22 治療脂肪肝疾病的方法 HK1216614A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13/801,697 US20140274979A1 (en) 2013-03-13 2013-03-13 Method for the treatment of fatty liver disease
PCT/US2013/072092 WO2014158242A1 (en) 2013-03-13 2013-11-26 Method for the treatment of fatty liver disease

Publications (1)

Publication Number Publication Date
HK1216614A1 true HK1216614A1 (zh) 2016-11-25

Family

ID=51529924

Family Applications (1)

Application Number Title Priority Date Filing Date
HK16104631.9A HK1216614A1 (zh) 2013-03-13 2016-04-22 治療脂肪肝疾病的方法

Country Status (12)

Country Link
US (4) US20140274979A1 (zh)
EP (1) EP2968217B1 (zh)
JP (1) JP6377713B2 (zh)
KR (1) KR20150130352A (zh)
CN (1) CN105209028B (zh)
BR (1) BR112015022571A2 (zh)
ES (1) ES2730739T3 (zh)
HK (1) HK1216614A1 (zh)
MX (1) MX2015012455A (zh)
SG (1) SG11201507181YA (zh)
TW (1) TWI631943B (zh)
WO (1) WO2014158242A1 (zh)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116440143A (zh) * 2015-11-19 2023-07-18 欣耀生医股份有限公司 预防或治疗脂肪肝的药物组合物
CN107343890A (zh) * 2016-05-06 2017-11-14 北京大学 牛樟芝及单体羊毛甾烷32在防治非酒精性脂肪肝中的应用
JP2019514986A (ja) * 2016-05-13 2019-06-06 ゴールデン バイオテクノロジー コーポレーション 進行期の非小細胞肺癌を処置するための方法および組成物
CN109862916A (zh) 2016-09-23 2019-06-07 普渡研究基金会 抗癌剂及其制备
JP2022523521A (ja) * 2019-02-25 2022-04-25 アージル・バイオテック・ホールディング・カンパニー・リミテッド ウイルス感染を阻害するための方法および組成物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090156614A1 (en) * 2006-07-19 2009-06-18 Dalton James T Selective androgen receptor modulators, analogs and derivatives thereof and uses thereof
CN101516835A (zh) * 2006-07-19 2009-08-26 俄亥俄州立大学研究基金会 选择性雄激素受体调节剂、它们的类似物和衍生物以及它们的用途
JP2008260695A (ja) * 2007-04-10 2008-10-30 Nissei Bio Kk 肝障害抑制剤
TWI394573B (zh) * 2007-06-14 2013-05-01 Golden Biotechnology Corp Application of Cynanchum auranthone Cyclohexenone Compounds in the Preparation of Drugs for Liver Protection
CN101785793A (zh) * 2009-01-23 2010-07-28 伟诚生物科技有限公司 保护肝脏及增进身体免疫调节功能的樟芝萃取物胶囊用途
EP2573081B1 (en) * 2010-05-19 2017-07-12 Kowa Company Ltd. Prophylactic and/or therapeutic agent for non-alcoholic steatohepatitis
US8309611B2 (en) * 2010-09-20 2012-11-13 Golden Biotechnology Corporation Methods and compositions for treating lung cancer

Also Published As

Publication number Publication date
BR112015022571A2 (pt) 2017-07-18
US20210177775A1 (en) 2021-06-17
WO2014158242A1 (en) 2014-10-02
US20140274979A1 (en) 2014-09-18
US20200093757A1 (en) 2020-03-26
EP2968217B1 (en) 2019-03-13
CN105209028B (zh) 2019-06-14
TW201440759A (zh) 2014-11-01
ES2730739T3 (es) 2019-11-12
MX2015012455A (es) 2016-04-07
KR20150130352A (ko) 2015-11-23
US10959963B2 (en) 2021-03-30
JP2016512238A (ja) 2016-04-25
SG11201507181YA (en) 2015-10-29
JP6377713B2 (ja) 2018-08-22
EP2968217A1 (en) 2016-01-20
US20170304224A1 (en) 2017-10-26
EP2968217A4 (en) 2016-11-02
CN105209028A (zh) 2015-12-30
TWI631943B (zh) 2018-08-11

Similar Documents

Publication Publication Date Title
HK1218078A1 (zh) 非酒精性脂肪性肝病治療劑
IL243976A0 (en) kdm1a inhibitors for disease treatment
HK1225305A1 (zh) 治療腦疾病的方法和組合物
SG11201701723XA (en) Methods of treating liver disease
EP2958936A4 (en) METHOD AND COMPOSITIONS FOR TREATING CORI DISEASE
IL244042B (en) A method for treating lyphtic disease
HK1219653A1 (zh) 治療線粒體疾病的方法
IL245474B (en) Process for preparing 5-fluoro-1h-pyrazoles
HK1216614A1 (zh) 治療脂肪肝疾病的方法
IL245476A0 (en) Process for preparing 5-fluoro-1h-pyrazoles
HK1223547A1 (zh) 癌症治療方法
IL243637A0 (en) PPAR-sparing compounds for the treatment of metabolic diseases
IL241096A0 (en) Treatment methods
PT3038596T (pt) Composições e métodos para a remoção de tatuagens
EP3021873A4 (en) METHODS OF TREATING JOINT INFLAMMATORY DISEASE
IL229326A (en) Process for making n-iodine-affluent
HK1221681A1 (zh) 用於治療神經退化的方法
PL3233074T3 (pl) Leczenie niealkoholowych stłuszczeniowych chorób wątroby
GB201301975D0 (en) New method for the purpose of safening
IL246188B (en) A process for the preparation of tiacomycin
GB201321628D0 (en) Treatment of disease
GB201322778D0 (en) Method of treatment
GB201314882D0 (en) Method of treatment